Allinaire Therapeutics
PrivateLast Round
Seed Round
Apr 14, 2026
Total Funding Raised
$2.83M
Momentum Score
25 /100
Company Overview
Allinaire Therapeutics is a biotechnology company developing novel therapeutics for cardiopulmonary diseases, including pulmonary arterial hypertension (PAH) and chronic obstructive pulmonary disease (COPD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allinaire Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Allinaire Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 14, 2026 | ||||
| Strategic | May 2, 2022 | ||||
| Grant | Sep 19, 2017 | ||||
| Seed | Jan 26, 2017 |
Key People
Founding team and executive leadership
Allinaire Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioMotiv | Seed |
| United States Department of Defense | Grant |
| BioCrossroads | Seed |
| Innovate Indiana Fund | Seed |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 77% MoM.
- Apr 14, 2026
$700K raised in Seed Round.
Allinaire Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Allinaire Therapeutics's valuation, stock price, and market status.
